Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food & Drug Administration has granted tentative approval to Aurobindo Pharma for manufacturing and marketing Famciclovir tablets 125mg, 250mg and 500mg.
Subscribe to our email newsletter
Aurobindo Pharma‘s Famciclovir tablets 125mg, 250mg and 500mg are the generic version of Novartis Pharmaceuticals’ Famvir tablets 125mg, 250mg and 500mg and is indicated for the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients and suppression of recurrent genital herpes in immunocompetent patients.
Aurobindo Pharma is headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients.